As of May 27
| +0.11 / +2.70%|
The 3 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 18.75, with a high estimate of 24.00 and a low estimate of 11.50. The median estimate represents a +347.49% increase from the last price of 4.19.
The current consensus among 3 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.